BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,206,000 | +3.0% | 7,975 | -0.7% | 0.01% | +25.0% |
| Q2 2022 | $1,171,000 | -16.7% | 8,033 | -32.2% | 0.00% | +33.3% |
| Q1 2022 | $1,405,000 | -25.1% | 11,849 | -13.0% | 0.00% | -25.0% |
| Q4 2021 | $1,876,000 | +58.7% | 13,613 | +60.0% | 0.00% | +33.3% |
| Q3 2021 | $1,182,000 | -13.2% | 8,508 | -39.3% | 0.00% | -25.0% |
| Q2 2021 | $1,361,000 | +54.8% | 14,017 | +9.0% | 0.00% | +33.3% |
| Q1 2021 | $879,000 | -3.8% | 12,858 | +20.6% | 0.00% | 0.0% |
| Q4 2020 | $914,000 | +138.6% | 10,660 | +80.8% | 0.00% | +50.0% |
| Q3 2020 | $383,000 | -18.3% | 5,897 | -8.0% | 0.00% | -33.3% |
| Q2 2020 | $469,000 | +62.3% | 6,413 | +21.0% | 0.00% | +200.0% |
| Q4 2019 | $289,000 | – | 5,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |